Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer:A Dutch population based study

Background: Substantial variation in the use of (neo) adjuvant treatment in patients with gastric cancer exists. The aim of this study was to identify underlying (organizational and process) factors associated with the use of perioperative therapy. Patients and methods: Patients with resectable gastric cancer who underwent surgery between 2012 and 2014 were selected from the Dutch Upper gastrointestinal Cancer Audit (DUCA). The proportion of perioperatively treated patients was defined per hospital. Five hospitals with the lowest percentage (LP group) and 5 hospitals with the highest percentag... Mehr ...

Verfasser: Beck, N.
Busweiler, L. A.D.
Schouwenburg, M. G.
Fiocco, M.
Cats, A.
Voncken, F. E.M.
Wijnhoven, B. P.L.
van Berge Henegouwen, M. I.
Wouters, M. W.J.M.
van Sandick, J. W.
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Reihe/Periodikum: Dutch Upper GI Cancer Audit (DUCA) Group and the Dutch Gastric Cancer Perioperative Therapy Study group , Beck , N , Busweiler , L A D , Schouwenburg , M G , Fiocco , M , Cats , A , Voncken , F E M , Wijnhoven , B P L , van Berge Henegouwen , M I , Wouters , M W J M & van Sandick , J W 2018 , ' Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer : A Dutch population based study ' , European Journal of Surgical Oncology , vol. 44 , no. 2 , pp. 260-267 . https://doi.org/10.1016/j.ejso.2017.11.023
Schlagwörter: Combined modality therapy / Quality assurance / Stomach neoplasms
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29029175
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/11370/f0f9334f-5fe4-4d90-9770-28bc74c7dd12